Cost Effectiveness of First-Line Treatment with Doxorubicin/Ifosfamide Compared to Trabectedin Monotherapy in the Management of Advanced Soft Tissue Sarcoma in Italy, Spain, and Sweden

Guest, JF; Panca, M; Sladkevicius, E; Gough, N; Linch, M; (2013) Cost Effectiveness of First-Line Treatment with Doxorubicin/Ifosfamide Compared to Trabectedin Monotherapy in the Management of Advanced Soft Tissue Sarcoma in Italy, Spain, and Sweden. Sarcoma , 2013 pp. 1-19. 10.1155/2013/725305 . Green open access

http://ift.tt/2p4BWzt